SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to a significant drop following Phase 3 trial data, which, despite showing statistical significance in one analysis, was impacted by a high placebo response in another. The community is debating whether this drop is an overreaction, citing the company's cash runway, other pipeline products, and previous buyout rumors as reasons for potential recovery. Bullish investors believe long-term prospects remain strong, while others express concern over the trial results and potential implications for the company's future.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

$WEEDCOIN.X is trending as community members rally around the crypto's connection to cannabis culture and a shared vision of positivity. Advocates emphasize that $WEEDCOIN.X represents more than just a token; it's a movement towards freedom, community, and growth, aiming to bridge the gap between cannabis enthusiasts and the digital economy.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals ($ENTA) is trending as investors anticipate topline results from its Phase 2b study of Zelicapavir for RSV, expected to be released soon. Bullish sentiment is building, with some traders hoping for a significant price increase if the data proves positive. The community is actively seeking insights and analysis to gauge the potential outcome of the study.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to the appointment of Barbara Humpton as the new CEO, effective October 1, 2025; the community is discussing her extensive experience and the company's strategic focus on becoming a leading supplier of rare earth minerals and magnets. Conversations also involve speculation around government deals and potential investment, along with options activity and price targets.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement of approximately $44 million, leading to significant after-hours price movement. Community discussions revolve around the stock's small float, potential for a squeeze, and the impact of warrants associated with the deal. Some traders are optimistic about continued upward momentum, while others express concerns about potential dilution.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

MSOX is trending as investors discuss potential catalysts for cannabis stocks, including regulatory reform and rescheduling. Community members are debating whether to buy and hold for long-term growth or trade on short-term price movements, while some are expressing frustration with the ETF's performance relative to its underlying assets. The broader context involves speculation around political developments and potential shifts in market sentiment towards the cannabis sector.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics ($AVTX) is trending due to recent surges in volume and price, sparking speculation about a potential short squeeze or upcoming news catalyst. Community discussions revolve around the possibility of significant upside, comparing it to similar stocks with low floats, while also referencing analyst upgrades and price target increases. The stock's volatility and potential for further gains are key talking points.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending as investors anticipate data from its nomlabofusp clinical development program for Friedreich's Ataxia, expected sometime this month. Community members are weighing the potential for positive results and a subsequent rise in stock price, while also considering the risk of negative outcomes given the high short interest and upcoming conference call to discuss updates. Some traders are noting unusual options activity, suggesting significant potential movement in either direction post-announcement.

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Merus N.V

Merus is trending after Genmab announced its acquisition of the company for $97 per share, a deal valued at $8 billion, to gain access to a promising head and neck cancer drug. The community is buzzing about the buyout price and the strategic implications for Genmab as it aims to become a global biotech leader. Some traders are expressing regret for previously selling their shares while others are eyeing similar companies as potential takeover targets.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as the community discusses the potential impact of cannabis rescheduling following Trump's recent comments and a new $50 million share repurchase program. Community talking points include tax relief, increased profitability for US cannabis companies, and advantages over Canadian competitors. Some investors view GTBIF as a strong, profitable US-based company poised to benefit from regulatory changes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rocket Lab vs. Planet Labs: Which Space Stock Stands Stronger in 2025?

RKLB and PL gain investor attention as satellite demand, government spending and tech advances fuel growth in the space sector.

Company News for Sep 9, 2025

Companies in The News Are: APP, SATS, PL, PCG

U.S. equities rose in Monday’s midday trade as investors await the crucial inflation print to be released on Wednesday to get better clues about the Federal Reserve’s monetary policy direction.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.15% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq, rose 0.51%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, declined by 0.08%.Here are the top stocks making the biggest moves in Monday’s midday trade:<a href="https://stocktwits.com/symbol/ASTS">AST SpaceMobile Inc. (ASTS)</a>AST SpaceMobile Inc. (ASTS) shares&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-asts-stock-falling-today-after-spacex-echostar-deal/chwWyHXRdr3">were down</a> more than 9% in Monday’s midday trade after SpaceX&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/echostar-to-dell-17-billion-in-spectrum-assets-to-spacex/chwWH3JRdAD">agreed</a> to acquire spectrum from EchoStar Corp. (SATS) in a deal valued at $17 billion.<a href="https://stocktwits.com/symbol/ASTS">ASTS stock</a> is up 84% year-to-date.<a href="https://stocktwits.com/symbol/APP">AppLovin Corp. (APP)</a>AppLoving shares hit a record&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/app-shares-hit-all-time-high-hood-stock-nears-record-after-s-and-p-500-inclusion/chwhbpxRdrg">high</a> on Monday, soaring nearly 11% after being included in the S&amp;P 500 index as of September 22. AppLovin replaced MarketAxess Holdings (MKTX) in the benchmark index, according to S&amp;P Dow Jones Indices.<a href="https://stocktwits.com/symbol/APP">APP stock</a> is up 67% year-to-date.<a href="https://stocktwits.com/symbol/OCTO">Eightco Holdings Inc. (OCTO)</a>Eightco’s shares&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dan-ives-set-to-join-octo-as-chairman-raises-250-m-for-worldcoin-treasury/chwWw7lRdrG">skyrocketed</a> on Monday, trading up by 4,300% in Monday’s midday trade after the company announced that Dan Ives, Managing Director at Wedbush Securities, will join the company as its chairman. The company also announced plans to raise $250 million through a private placement.<a href="https://stocktwits.com/symbol/OCTO">OCTO stock</a> is up 2,787% year-to-date.<a href="https://stocktwits.com/symbol/HOOD">Robinhood Markets Inc. (HOOD)</a>Robinhood shares&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-rise-as-investors-look-out-for-key-inflation-data/chwWvU5RdAy">surged</a> over 15% in Monday’s midday trade following an announcement on late Friday that it will join the S&amp;P 500 index on September 22. Robinhood will replace Caesars Entertainment Inc. (CZR) on the benchmark index.<a href="https://stocktwits.com/symbol/HOOD">HOOD stock</a> is up 211% year-to-date.<a href="https://stocktwits.com/symbol/PL">Planet Labs PBC (PL)</a>Planet Labs shares&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-planet-labs-stock-rocket-over-35-percent-today/chwhRfiRdrh">ripped</a> more than 35% after the company’s second-quarter (Q2) results beat Wall Street expectations. Planet Labs reported a loss of $0.03 per share on revenue of $73 million, while analysts expected a loss of $0.05 per share on revenue of $66 million, according to Stocktwits data.<a href="https://stocktwits.com/symbol/PL">PL stock</a> is up 118% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/stubhub-ipo-price-valuation-9-billion/chwh2AvRdrj">StubHub IPO Price Values The Company At Over $9 Billion: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

AST SpaceMobile, AppLovin, Eightco, Robinhood, Planet Labs: Stocks Making The Biggest Moves Today

AST SpaceMobile shares were down more than 9% in Monday’s midday trade after SpaceX agreed to acquire spectrum from EchoStar in a deal valued at $17 billion.

Equity

Planet Labs PBC (PL) executives stated during the company’s second-quarter earnings call that it is well-positioned to ride the AI wave and its leadership is poised to deliver sustained profitability and cash generation.&nbsp;CEO William Marshall emphasized the company’s readiness to capitalize on ongoing opportunities. “We're capitalizing on the ongoing AI revolution, for which we're extremely well positioned, and we've made excellent progress in our profitability goals and on building a strong cash flow-generating business for the long term,” Marshall said during the call.&nbsp;<a href="https://stocktwits.com/symbol/PL">Planet Labs' stock</a> jumped over 36% by Monday mid-morning. On Stocktwits, retail sentiment toward the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day while message volume shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:937/111;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_08_105413_png_a54ef514a6.webp" alt="PL’s Sentiment Meter and Message Volume as of 10:45 a.m. ET on Sep. 8, 2025 | Source: Stocktwits" width="937" height="111"><figcaption>PL’s Sentiment Meter and Message Volume as of 10:45 a.m. ET on Sep. 8, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 1,200% surge in user message count in the last week. A bullish Stocktwits user called the stock ‘outstanding’.<stembedurl>https://stocktwits.com/Counselor53/message/627811555</stembedurl>Planet Lab’s President and CFO, Ashley Whitfield Johnson, highlighted the growing adoption of AI-enabled offerings across government agencies, the agriculture sector, and the energy sector. ‘We're pleased to see the strong uptake of our AI-enabled solutions in the government markets as well as the health of our customer relationships in the agricultural and energy sectors,” said Johnson.&nbsp;The company’s Q2 revenue jumped 20% year-on-year (YoY) to $73.4 million, surpassing the analysts’ consensus estimate of $66.15 million, according to Fiscal AI data.&nbsp;The adjusted loss per share of $0.03 also came in narrower than the estimated loss of $0.04.The operating cash flow for the quarter totaled $67.7 million with a free cash flow of $46.3 million. The company held $181 million in cash and equivalents as of July 31. Planet Labs stock has gained over 119% year-to-date and over 362% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lithium-battery-maker-quantumscape-stock-surged-over-27-percent-today/chwW6L4Rdr9">Lithium Battery Maker QuantumScape Stock Surged Over 27% Today – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone held in a hand shows the logo of Planet Labs PBC

Why Did Planet Labs Stock Rocket Over 35% Today?

The company’s Q2 revenue jumped 20% year-on-year to $73.4 million, surpassing the analysts’ consensus estimate of $66.15 million, according to Fiscal AI data. 

Planet Labs PBC (PL) Reports Q2 Loss, Beats Revenue Estimates

Planet Labs PBC (PL) delivered earnings and revenue surprises of 0.00% and +11.40%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Guidewire Software (GWRE) Q4 Earnings and Revenues Surpass Estimates

Guidewire Software (GWRE) delivered earnings and revenue surprises of +35.48% and +5.76%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

BKSY's Growth Driven by Strong Government Contract Momentum

BlackSky's recurring government contracts fuel revenue growth and boost its standing in the competitive space and defense tech sector.

Lantronix, Inc. (LTRX) Q4 Earnings Meet Estimates

Lantronix (LTRX) delivered earnings and revenue surprises of 0.00% and +1.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BKSY Stock Falls 28% in a Month: Should You Buy the Dip or Wait?

BlackSky shares tumble in a month. Though Gen-3 satellite launches and new funding fuel growth, losses and guidance cuts raise caution.

Kimball Electronics (KE) Surpasses Q4 Earnings and Revenue Estimates

Kimball Electronics (KE) delivered earnings and revenue surprises of +70.00% and +13.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.03	--	--	N/A
Q2 '25	-$0.05	-$0.03	38.75%	BEAT
Q1 '25	-$0.04	$0.00	100.00%	BEAT
Q4 '24	-$0.02	-$0.08	-244.00%	MISSED
Q3 '24	-$0.05	-$0.02	61.80%	BEAT

PL
Planet Labs PBC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest PL News

PL Planet Labs PBC